Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

One of the current challenges in vaccine design is the development of antigen delivery systems or vaccination strategies that induce high protective levels of CD8+ T cells. These cells are crucial for protection against certain tumours and intracellular pathogens such as the liver-stage parasite of...

Bibliografske podrobnosti
Main Authors:	Schneider, J, Gilbert, S, Hannan, C, Dégano, P, Prieur, E, Sheu, E, Plebanski, M, Hill, A
Format:	Journal article
Jezik:	English
Izdano:	1999

Podobne knjige/članki

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
od: Hill, A, et al.
Izdano: (2000)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
od: Gilbert, S, et al.
Izdano: (2002)

Prime-boost immunisation strategies for tuberculosis.
od: Mcshane, H, et al.
Izdano: (2005)

Optimizing HIV-1-specific CD8 + T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
od: Hopkins, R, et al.
Izdano: (2011)

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
od: Hopkins, R, et al.
Izdano: (2011)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting
od: Dean, G, et al.
Izdano: (2014)

Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.
od: Dean, G, et al.
Izdano: (2014)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
od: Dégano, P, et al.
Izdano: (1999)

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
od: Moore, A, et al.
Izdano: (2004)

Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles
od: Anson Donald S, et al.
Izdano: (2011-09-01)

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.
od: Anderson, R, et al.
Izdano: (2004)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
od: Draper, S, et al.
Izdano: (2005)

A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.
od: Henrique Roman Ramos, et al.
Izdano: (2016-03-01)

Heterologous Prime-boost COVID-19 Vaccination
od: Vishal R. Tandon, et al.
Izdano: (2021-10-01)

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.
od: Taracha, E, et al.
Izdano: (2003)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
od: Schneider, J, et al.
Izdano: (1998)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
od: Ogwang, C, et al.
Izdano: (2013)

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
od: Dunachie, S, et al.
Izdano: (2006)

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.
od: Hanke, T, et al.
Izdano: (1998)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
od: Vuola, J, et al.
Izdano: (2005)

Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells.
od: Behboudi, S, et al.
Izdano: (2004)

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
od: Schneider, J, et al.
Izdano: (2001)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
od: Caroline Ogwang, et al.
Izdano: (2013-01-01)

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8<sup>+ </sup>T cell immunity
od: Obrocea Mihail, et al.
Izdano: (2010-12-01)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
od: Ramirez-Valdez, RA
Izdano: (2021)

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
od: Yuting Pan, et al.
Izdano: (2020-05-01)

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin.
od: Vordermeier, H, et al.
Izdano: (2004)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
od: Shaw, RH, et al.
Izdano: (2021)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
od: Om Prakash Choudhary, et al.
Izdano: (2021-12-01)

Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.
od: Plebanski, M, et al.
Izdano: (1998)

Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responses.
od: Plebanski, M, et al.
Izdano: (2005)

LFA-1 Mediates Cytotoxicity and Tissue Migration of Specific CD8+ T Cells after Heterologous Prime-Boost Vaccination against Trypanosoma cruzi Infection
od: Camila Pontes Ferreira, et al.
Izdano: (2017-10-01)

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice
od: Xingxing Li, et al.
Izdano: (2023-03-01)

Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: evidence for protection and antigen synergy.
od: Gharbi, M, et al.
Izdano: (2011)

Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: Evidence for protection and antigen synergy
od: Gharbi, M, et al.
Izdano: (2011)

CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
od: Tara Elvang, et al.
Izdano: (2009-01-01)

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees
od: Biberfeld G, et al.
Izdano: (2009-10-01)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
od: Rühl, J, et al.
Izdano: (2019)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
od: Ros Chapman, et al.
Izdano: (2021-11-01)

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
od: Tesfaye Gelanew, et al.
Izdano: (2023-01-01)